Special Issue "Transition from Nutraceuticals to Nano-Nutraceuticals and Nano-Pharmaceuticals: Impact on Health and Diseases"

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Biomedical Materials and Nanomedicine".

Deadline for manuscript submissions: closed (15 December 2019) | Viewed by 4208

Special Issue Editor

1. The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive (Room 238), Rensselaer, NY 12144, USA
2. Vascular Vision Pharmaceuticals Co., Rensselaer Polytechnic Park, Troy, NY 12180 USA
Interests: pharmaceuticals; biopharmaceuticals and diagnostics; nanomedicine; cardiovascular diseases; neurological disorders; hematology and oncology; biosimilar and nanosimilar; angiogenesis; inflammation; thrombosis; integrin and cell adhesion molecules; target identification; molecular mechanisms and signaling pathways; preclinical; clinical; marketing and post marketing studies; regulatory and ethical issues
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Medicinal plants have been utilized in all societies as a wellspring of therapeutic use and drug discovery. Traditional medication utilizes plant-, animal-, and marine-based drugs; spiritual treatments; and manual procedures and activities to treat, diagnose, and avert illnesses. In spite of advancements in recent decades with regard to therapeutics, pharmacological approaches, and new restorative innovations, a high percentage of the population still depends on traditional medicine for their essential health care needs. Despite the fact that fruitful or successful traditional medication use has not always been realized, there remains a strong reliance on a huge range of natural products isolated from plants, animals, and some microorganism or marine sources. Natural medications used to treat various illnesses for long periods of time have provided a significant incentive to the cutting-edge pharmaceutical industry over the past 50 years.

In this Special Issue, we will feature the advancement accomplished in the most recent decades in traditional medicines inspired by natural products. Additionally, we will consider how natural products utilized in the past gave a valuable platform to the advancement of pharmaceutical industry, and current approaches to going from nature, to the bench, to the bedside. Furthermore, to truly capitalize on such approaches, pharmacokinetic (PK), pharmacodynamics (PD, efficacy), and safety regarding traditional medicine quality, use, and standardization will be addressed.

The impact of nanobiotechnology on improving the PK and PD of nutraceuticals, which would accelerate the transition from nutraceuticals to nano-nutraceuticals to pharmaceuticals and nanopharmaceuticals, will be a key emphasis of this Special Issue. 

Prof. Dr. Shaker Mousa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • nutraceuticals
  • nano nutraceuticals
  • nutraceuticals to pharmaceuticals
  • alternative and complimentary medicine
  • natural products
  • herbal medicines
  • disease prevention
  • nanoformulations
  • plant bioactive compounds
  • marine- and animal-derived products

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
Biomedicines 2020, 8(9), 347; https://doi.org/10.3390/biomedicines8090347 - 12 Sep 2020
Cited by 37 | Viewed by 3725
Nanotechnology is the science of nanoscale, which is the scale of nanometers or one billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials, and manufacturing processes that are used to design and/or enhance many products, including medicinal products. This technology [...] Read more.
Nanotechnology is the science of nanoscale, which is the scale of nanometers or one billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials, and manufacturing processes that are used to design and/or enhance many products, including medicinal products. This technology has achieved considerable progress in the oncology field in recent years. Most chemotherapeutic agents are not specific to the cancer cells they are intended to treat, and they can harm healthy cells, leading to numerous adverse effects. Due to this non-specific targeting, it is not feasible to administer high doses that may harm healthy cells. Moreover, low doses can cause cancer cells to acquire resistance, thus making them hard to kill. A solution that could potentially enhance drug targeting and delivery lies in understanding the complexity of nanotechnology. Engineering pharmaceutical and natural products into nano-products can enhance the diagnosis and treatment of cancer. Novel nano-formulations such as liposomes, polymeric micelles, dendrimers, quantum dots, nano-suspensions, and gold nanoparticles have been shown to enhance the delivery of drugs. Improved delivery of chemotherapeutic agents targets cancer cells rather than healthy cells, thereby preventing undesirable side effects and decreasing chemotherapeutic drug resistance. Nanotechnology has also revolutionized cancer diagnosis by using nanotechnology-based imaging contrast agents that can specifically target and therefore enhance tumor detection. In addition to the delivery of drugs, nanotechnology can be used to deliver nutraceuticals like phytochemicals that have multiple properties, such as antioxidant activity, that protect cells from oxidative damage and reduce the risk of cancer. There have been multiple advancements and implications for the use of nanotechnology to enhance the delivery of both pharmaceutical and nutraceutical products in cancer prevention, diagnosis, and treatment. Full article
Back to TopTop